What regimens eradicate Helicobacter pylori?

Journal of Family Practice

Volumn 52, Issue 10, 2003, Pages 799-803

  Malaty, Wail ^a   Stigleman, Sue ^a   Hansen, Laura B ^b  

^a Mt Area Health Education Center   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE;

DRUG EFFICACY; DRUG WITHDRAWAL; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; REVIEW; SIDE EFFECT;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTITRICHOMONAL AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; EVIDENCE-BASED MEDICINE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PRACTICE GUIDELINES; PROTON PUMPS;

EID: 0141919608     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Heliobacter Pylori Study Group. Gut 1997; 41:8-13.
2. Calvet X, Garcia N, Lopez T, Gisbert JP, Gene E, Roque M. A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxicillin for treating Helicobacter pylori infection. Aliment Pharmacol Ther 2000; 14:603-609.
3. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin, and amoxicillin or metronidazole. Aliment Pharmacol Ther 1999; 13:719-729.
4. Janssen MJ, Van Oijen AH, Verbeek AL, Jansen JB, De Boer WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole. Aliment Pharmacol Ther 2001; 15:613-624.
5. Delaney B, Moayyedi, P, Forman, D. Helicobacter pylori. Clin Evid [online], Issue 8. London: BMJ Publishing Group, Last updated 2003 March. Available at www.ovid.com. Accessed on March 4, 2003.
6. Treiber G, Wittig J, Ammon S, Walker S, van Doorn LJ, Klotz U. Clinical outcome and influencing factors for a new short-term quadruple therapy for Heliobacter pylori eradication: a randomized controlled trial (MACLOR study). Arch Intern Intem Med 2002; 162:153-160.
7. Wong BC, Wang WH, Wong WM, et al. Three-day lansoprazole quadruple therapy for Heliobacter pylori-positive duodenal ulcers: a randomized controlled study. Aliment Pharmacol Ther 2001; 15:843-849.
8. Howden CW, Hunt RH, Guidelines for the management of Heliobacter pylori infection. Ad Hoc Committee on the Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93:2330-2338.
9. Institute for Clinical Systems Improvement (ICSI). Dyspepsia. Bloomington, Minn: ICSI; last updated January 2003. Available at: http://www.icsi.org/ knowledge/detail.asp?catID=29&itemID=171. Accessed on September 8, 2003.